Voriconazole NDC 16714-199

NDC codes

FDA NDC Directory

Product NDC (as listed)16714-199Labeler and product segments. Claims need a package NDC.

Product NDC at billing width16714-0199Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
16714-199-01	16714019901	30 TABLET, FILM COATED in 1 BOTTLE (16714-199-01)Marketed from Jan 22, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Voriconazole
Generic name (nonproprietary): voriconazole
Active ingredients: Voriconazole — 200 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: NorthStar Rx LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206837
Marketing start: Jan 22, 2016
Marketing end: Apr 30, 2027
Other FDA classes: Azoles (Chemical structure)Cytochrome P450 2C19 Inhibitors (Mechanism)Cytochrome P450 2C9 Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)
Identifiers: Product ID 16714-199_45de5a3f-4e1f-4870-b4aa-3057e4e2ba7fSPL ID 45de5a3f-4e1f-4870-b4aa-3057e4e2ba7fSPL set ID b38165a5-d8d4-4579-a49a-fbe92e764089RxCUI 349434, 349435UNII JFU09I87TRUPC 0316714198019, 0316714199016
Pharmacologic class: Azole Antifungal

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N416714019901 followed by a unit qualifier and the quantity

Package 16714-0199-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 2, 2025.

Indications (excerpt from the label)

Voriconazole tablets are an azole antifungal indicated for the treatment of adults and pediatric patients 2 years of age and older with: Invasive aspergillosis ( 1.1 ) Candidemia in non-neutropenics and other deep tissue Candida infections ( 1.2 ) Esophageal candidiasis ( 1.3 ) Serious fungal infections caused by Scedosporium apiospermum and Fusarium species including Fusarium solani , in patients intolerant of, or refractory to, other therapy ( 1.4 ) 1.1 Invasive Aspergillosis Voriconazole tablets are indicated in adults and pediatric patients (2 years of age and older) for the treatment of invasive aspergillosis (IA). In clinical trials, the majority of isolates recovered were Aspergillus …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 206837

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206837
Product	Strength	Form · route	Labeler	Product NDC
Voriconazole	Voriconazole 50 mg/1	Tablet, Film coatedOral	NorthStar Rx LLC	16714-198
Voriconazole	Voriconazole 50 mg/1	Tablet, Film coatedOral	American Health Packaging	60687-968
Voriconazole	Voriconazole 200 mg/1	Tablet, Film coatedOral	American Health Packaging	60687-979
Voriconazole	Voriconazole 200 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	65862-892
Voriconazole	Voriconazole 50 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	65862-891